Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica T Davis

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Potential impact of annual vaccination with reformulated COVID-19 vaccines: lessons from the U.S. COVID-19 Scenario Modeling HubSung-Mok Jung, Sara L Loo, Emily Howerton, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2022
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studyRebecca K Borchering, Luke C Mullany, Emily Howerton, et al.
Lancet Regional Health. Americas|November 28, 2022
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model studyRebecca K Borchering, Luke C Mullany, Emily Howerton, et al.
Elife|June 21, 2022
Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationShaun Truelove, Claire P Smith, Michelle Qin, et al.
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationShaun Truelove, Claire P Smith, Michelle Qin, et al.
MMWR. Morbidity and Mortality Weekly Report|May 14, 2021
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021Rebecca K Borchering, Cécile Viboud, Emily Howerton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Informing pandemic response in the face of uncertainty. <i>An evaluation of the U.S. COVID-19 Scenario Modeling Hub</i>Emily Howerton, Lucie Contamin, Luke C Mullany, et al.
Nature Communications|November 20, 2023
Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertaintyEmily Howerton, Lucie Contamin, Luke C Mullany, et al.
Plos Computational Biology|May 6, 2024
Challenges of COVID-19 Case Forecasting in the US, 2020-2021Velma K Lopez, Estee Y Cramer, Robert Pagano, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Potential impact of annual vaccination with reformulated COVID-19 vaccines: lessons from the U.S. COVID-19 Scenario Modeling HubSung-Mok Jung, Sara L Loo, Emily Howerton, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2022
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studyRebecca K Borchering, Luke C Mullany, Emily Howerton, et al.
Lancet Regional Health. Americas|November 28, 2022
Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model studyRebecca K Borchering, Luke C Mullany, Emily Howerton, et al.
Elife|June 21, 2022
Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationShaun Truelove, Claire P Smith, Michelle Qin, et al.
Medrxiv : the Preprint Server for Health Sciences|September 8, 2021
Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccinationShaun Truelove, Claire P Smith, Michelle Qin, et al.
MMWR. Morbidity and Mortality Weekly Report|May 14, 2021
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021Rebecca K Borchering, Cécile Viboud, Emily Howerton, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Informing pandemic response in the face of uncertainty. <i>An evaluation of the U.S. COVID-19 Scenario Modeling Hub</i>Emily Howerton, Lucie Contamin, Luke C Mullany, et al.
Nature Communications|November 20, 2023
Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertaintyEmily Howerton, Lucie Contamin, Luke C Mullany, et al.
Plos Computational Biology|May 6, 2024
Challenges of COVID-19 Case Forecasting in the US, 2020-2021Velma K Lopez, Estee Y Cramer, Robert Pagano, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Evaluation of FluSight influenza forecasting in the 2021-22 and 2022-23 seasons with a new target laboratory-confirmed influenza hospitalizationsSarabeth M Mathis, Alexander E Webber, Tomás M León, et al.
Pageof 4